Emergence of fluoroquinolone-resistant tuberculosis in New York City
暂无分享,去创建一个
T. Frieden | J. Musser | V. Kapur | E. Sullivan | B. Kreiswirth | A. Ebrahimzadeh | Barry N. Kreiswirth | L. Palumbo | B. Kreiswirth | E. A. Sullivan
[1] V. Jarlier,et al. Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. , 1994, The Journal of infectious diseases.
[2] A. Telenti,et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations , 1994, Antimicrobial Agents and Chemotherapy.
[3] A. Ramsay,et al. Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis. , 1993, The American review of respiratory disease.
[4] M. Spino,et al. Ciprofloxacin in Patients with Mycobacterial Infections: Experience in 15 Patients , 1991, DICP : the annals of pharmacotherapy.
[5] D van Soolingen,et al. Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology of tuberculosis , 1990, Journal of clinical microbiology.
[6] C. Collins,et al. In-vitro susceptibility of mycobacteria to ciprofloxacin. , 1985, The Journal of antimicrobial chemotherapy.
[7] A. Telenti,et al. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. , 1995, Archives of pathology & laboratory medicine.